Skip to main content

Table 3 Correlation between chemotherapy response and SMI, SMD, and their rate of change

From: Clinical significance of skeletal muscle density and sarcopenia in patients with pancreatic cancer undergoing first-line chemotherapy: a retrospective observational study

 

CR/PR (n = 60)

SD/PD (n = 191)

P

CR/PR/SD (n = 163)

PD (n = 88)

P

SMI

46.58 ± 11.46

46.62 ±12.07

0.981

47.21±11.94

45.44±10.88

0.249

SMI change (%)

−1.99 ± 11.46

−4.15±9.74

0.157

−3.95 ± 10.59

−3.05±9.77

0.501

SMD

43.27±7.95

43.48±7.52

0.856

43.58±8.22

42.85±7.09

0.484

SMD change (%)

−2.88 ± 11.45

−1.10±11.48

0.298

−1.67 ± 11.11

−1.26±12.17

0.784

  1. CR complete response, PD progressive disease, PR partial response, SD stable disease, SMD skeletal muscle density, SMI skeletal muscle index. Values are in Hounsfield units
Back to article page

BMC Cancer

ISSN: 1471-2407

Contact us